NYSE · UNH
UnitedHealth Group Incorporated
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
Loading market information…
NYSE · CVS · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CVS Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 18.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
CVS Health Corp.’s forward annual dividend is $2.66 per share, paid quarterly. The forward yield is 2.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
CVS Health Corp.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $1.65. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow CVS Health Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 1, 2025 | $2.25+32.35% vs estimate | $94.59B+0.97% vs estimate |
|---|
| Q4 2024 | Feb 12, 2025 | $1.19+30.2% vs estimate | $97.71B+0.64% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | $1.09-24.31% vs estimate | $95.43B+2.89% vs estimate |
|---|
THE ANALYST VIEW
41 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 16 contributors · Median target $112.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
$422.02+$7.61 (+1.84%)
Elevance Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.36% below the high.
$298.41+$3.41 (+1.16%)
Cigna Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.65% below the high.
$417.56+$5.69 (+1.38%)
Humana Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.53% below the high.
$68.62+$1.57 (+2.34%)
Centene Corp.’s quoted price sits in the upper half of its reported 52-week range, 5.35% below the high.
$198.95+$0.85 (+0.43%)
Molina Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.76% below the high.
$30.79+$0.31 (+1.02%)
Oscar Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.05% below the high.
$8.06-$0.12 (-1.47%)
Alignment Healthcare, Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.91% below the high.
